NIOX vs. SN, MXCT, EKF, IUG, CREO, NCYT, POLX, IHC, AVO, and RUA
Should you be buying NIOX Group stock or one of its competitors? The main competitors of NIOX Group include Smith & Nephew (SN), MaxCyte (MXCT), EKF Diagnostics (EKF), Intelligent Ultrasound Group (IUG), Creo Medical Group (CREO), Novacyt (NCYT), Polarean Imaging (POLX), Inspiration Healthcare Group (IHC), Advanced Oncotherapy (AVO), and RUA Life Sciences (RUA). These companies are all part of the "medical devices" industry.
NIOX Group vs.
Smith & Nephew (LON:SN) and NIOX Group (LON:NIOX) are both large-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, community ranking, profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.
In the previous week, NIOX Group had 3 more articles in the media than Smith & Nephew. MarketBeat recorded 4 mentions for NIOX Group and 1 mentions for Smith & Nephew. Smith & Nephew's average media sentiment score of 0.00 beat NIOX Group's score of -0.66 indicating that Smith & Nephew is being referred to more favorably in the media.
Smith & Nephew has a beta of 0.62, meaning that its share price is 38% less volatile than the S&P 500. Comparatively, NIOX Group has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500.
62.2% of Smith & Nephew shares are owned by institutional investors. Comparatively, 35.2% of NIOX Group shares are owned by institutional investors. 0.2% of Smith & Nephew shares are owned by insiders. Comparatively, 46.7% of NIOX Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
NIOX Group has a net margin of 28.21% compared to Smith & Nephew's net margin of 5.41%. NIOX Group's return on equity of 13.29% beat Smith & Nephew's return on equity.
NIOX Group has lower revenue, but higher earnings than Smith & Nephew. Smith & Nephew is trading at a lower price-to-earnings ratio than NIOX Group, indicating that it is currently the more affordable of the two stocks.
Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.7%. NIOX Group pays an annual dividend of GBX 1 per share and has a dividend yield of 1.6%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. NIOX Group pays out 4,126.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Smith & Nephew is clearly the better dividend stock, given its higher yield and lower payout ratio.
Smith & Nephew currently has a consensus price target of GBX 7,840, indicating a potential upside of 625.93%. NIOX Group has a consensus price target of GBX 90, indicating a potential upside of 43.31%. Given Smith & Nephew's higher probable upside, research analysts clearly believe Smith & Nephew is more favorable than NIOX Group.
Smith & Nephew received 557 more outperform votes than NIOX Group when rated by MarketBeat users. However, 100.00% of users gave NIOX Group an outperform vote while only 62.02% of users gave Smith & Nephew an outperform vote.
Summary
Smith & Nephew and NIOX Group tied by winning 9 of the 18 factors compared between the two stocks.
Get NIOX Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for NIOX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
NIOX Group Competitors List
Related Companies and Tools
This page (LON:NIOX) was last updated on 5/22/2025 by MarketBeat.com Staff